Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Grand Pharmaceutical
AddedFeb 15, 2024
UpdatedJun 28, 2026
Grand Pharmaceutical

Grand Pharmaceutical

Public

Grand Pharmaceutical: A GMP-certified global innovator in anti-tumor diagnosis, treatment, and medical equipment.

HQ
Wuhan, Hubei, CN
Overview
Compare
Employees
Website

Founded with a vision to revolutionize healthcare, Grand Pharmaceutical is a GMP-certified manufacturer specializing in pharmaceutical technology and nuclear drug anti-tumor diagnosis and treatment. The company offers a range of innovative medical equipment and services aimed at enhancing patient care. With a strong market focus on the United States, Australia, Germany, Belgium, and other countries, Grand Pharmaceutical is committed to delivering cutting-edge solutions with broad market prospects.

Notable for its global impact, Grand Pharmaceutical has achieved significant milestones in the medical field. The company has introduced a series of revolutionary medical devices that have gained traction in various international markets. Supported by a team of leading experts and investors in the healthcare industry, Grand Pharmaceutical continues to push the boundaries of medical technology, significantly improving diagnostic and treatment outcomes for patients worldwide.

Grand Pharmaceutical - Similar Companies

China Grand Pharmaceutical and Healthcare Holdings logo

China Grand Pharmaceutical and Healthcare Holdings

Pharmstandard logo

Pharmstandard

Medison Pharma logo

Medison Pharma

medisonpharma.com

Nobelpharma logo

Nobelpharma

ONO Pharmaceutical logo

ONO Pharmaceutical

Biophyx logo

Biophyx

biophyx.co

China PharmaHub logo

China PharmaHub

Pisa Biopharm logo

Pisa Biopharm

Novartis Pharma logo

Novartis Pharma

Taiho Pharmaceutical Co. logo

Taiho Pharmaceutical Co.

taiho.co.jp

A&G Pharmaceutical logo

A&G Pharmaceutical

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Solaris Pharma logo

Solaris Pharma

solaris-pharma.com

Gradient Pharmaceuticals logo

Gradient Pharmaceuticals

Kansas Laboratories logo

Kansas Laboratories

Grand Pharmaceutical - Quick Facts

Who are Grand Pharmaceutical's competitors?

Companies similar to Grand Pharmaceutical include China Grand Pharmaceutical and Healthcare Holdings, Pharmstandard, Medison Pharma and Nobelpharma.

Where is Grand Pharmaceutical's headquarters located?

Grand Pharmaceutical's headquarters is located in Wuhan, Hubei, CN.

How many employees does Grand Pharmaceutical have?

Grand Pharmaceutical has 1,000 employees as of Feb 4, 2024.

Grand Pharmaceutical - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Medical Equipment
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified